Page last updated: 2024-11-12

3-hydroxytibolone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-hydroxytibolone: tibolone metabolite [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10087021
SCHEMBL ID7019917
MeSH IDM0466405

Synonyms (18)

Synonym
3alpha-hydroxytibolone
3-hydroxytibolone
org 4094
100239-44-9
SCHEMBL7019917
(3.alpha.,7.alpha.,17.alpha.)-7-methyl-19-norpregn-5(10)-en-20-yne-3,17-diol
37T303O94A ,
3.alpha.-hydroxytibolone
19-norpregn-5(10)-en-20-yne-3,17-diol, 7-methyl-, (3.alpha.,7.alpha.,17.alpha.)-
org-4094
(3r,7r,8r,9s,13s,14s,17r)-17-ethynyl-7,13-dimethyl-2,3,4,6,7,8,9,11,12,14,15,16-dodecahydro-1h-cyclopenta[a]phenanthrene-3,17-diol
unii-37t303o94a
19-norpregn-5(10)-en-20-yne-3,17-diol, 7-methyl-, (3alpha,7alpha,17alpha)-
(3alpha,7alpha,17alpha)-7-methyl-19-norpregn-5(10)-en-20-yne-3,17-diol
3a-hydroxytibolone
Q27256698
3?-hydroxy tibolone
DTXSID001315905

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The validated method was applied in a pharmacokinetic study with a tibolone formulation in healthy female volunteers."( Determination of 3-α-hydroxytibolone in human plasma by LC-MS/MS: application for a pharmacokinetic study after administration of a tibolone formulation.
Bonfim, RR; César, IC; da Silva, EP; de Santana e Silva Cardoso, FF; de Souza Teixeira, L; de Souza, WC; Ferreira, DP; Gomes, SA; Lopes, AR; Mundim, IM; Pascoal, HD; Pianetti, GA, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
" In plasma, the predominant nonsulfated metabolite after single and multiple dosing was the estrogenic 3alpha-hydroxytibolone; levels of the estrogenic 3beta-hydroxytibolone were 10-fold lower and of progestagenic/androgenic Delta(4)-tibolone, 5-fold lower."( Pharmacokinetic parameters of tibolone and metabolites in plasma, urine, feces, and bile from ovariectomized cynomolgus monkeys after a single dose or multiple doses of tibolone.
Delbressine, LP; Kloosterboer, HJ; Timmer, CJ; van Iersel, ML; Verheul, HA, 2007
)
0.34
" Levels of disulfated metabolites in serum and tissues were higher (3- to 5-fold) after multiple dosing than after a single dose."( Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Verheul, HA, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (90.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.54 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]